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Abstract
Authors of Cochrane reviews are expected to update their reviews every 2 years. The updating process helps to ensure
that reviews are current and include recent evidence. However, the updating process is time-consuming for authors,
particularly when Cochrane methods evolve and authors are required to revisit some of the originally included studies.
The Cochrane Collaboration's ‘Risk of bias’ tool is a mandatory component of Cochrane reviews, providing an
assessment of the potential biases of included studies. The tool has been modified most recently in 2011, and the
expectation is that new versions will continue to be produced and utilised in all Cochrane reviews. In this
commentary we discuss, in the context of updating scenarios that are likely to be encountered, the potential options
systematic review authors may have recourse to when the Cochrane Collaboration's ‘Risk of bias’ tool has been modified
between the original review and its update. We recommend that authors who are updating reviews should revise their
original assessments of included studies using the most recent version of the risk of bias tool. Despite the increased
workload, use of the most recent version of the tool facilitates consistency of methods and reporting both across and
within reviews, and ensures currency to the methodological rigour.
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Background
The Cochrane Collaboration publishes systematic re-
views in the Cochrane Database of Systematic Reviews
(CDSR). Cochrane reviews, like non-Cochrane ones, are
expected to be current; and when authors agree to take
on and complete a Cochrane review, the expectation is
that the review will be updated every 2 years. This up-
date must include a new search for studies, and if new
studies are identified, they must be screened and the
relevant data extracted. A new synthesis including both
previously identified studies and newly found studies is
then published [1].
Updating systematic reviews is a challenge both for
review authors and others involved with the publication
process, such as peer reviewers and editors. Cochrane
updates are given a new citation as long as they include
a new recent search and a screening process for articles
[2]. There is a substantial amount of time and resources
required to complete any systematic review update.
The novelty of the original publication no longer
exists, and it is possible that the members of the
authorship team no longer collaborate or some team
members may have moved on to different areas of
research. In some cases, a new research team takes
over the review and carries out the update. Most of
the research on updating reviews has focused on sig-
nals identifying the need to update [3–8] and reasons
and methods for updating [9, 10]. Although authors
agree to update reviews when they take on the project
initially, approximately only 20 % of Cochrane reviews
are updated every 2 years [11].
One of the challenges of updating a review is incorporat-
ing new methods. The field of scientific writing continues
to evolve [12, 13]. The Cochrane Collaboration has 16
method groups, which specifically target and develop the
methods used in the conduct and reporting of systematic
reviews. In this commentary we discuss, in the context of
updating scenarios that are likely to be encountered, the po-
tential options systematic review authors may have recourse
to when the Cochrane Collaboration’s ‘Risk of bias’ (RoB)
tool has been modified between the original review and its
update. We recommend that in order to keep a review
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current, authors need to not only incorporate new evidence
but also utilise the most up-to-date methodological
guidance.
Recent history of Cochrane risk of bias assessment for
randomised trials
There have been significant changes to the Cochrane
RoB tool in the past 10 years. The three most recent
versions are described below and summarised in Table 1.
According to the Cochrane Handbook for Systematic
Reviews of Interventions (referred to as the Handbook
below) published in 2006, the recommendation was
made to assess selection bias, performance bias, attrition
bias and detection bias for every study [14], but only
allocation concealment was a mandatory component of
the RoB table in the Review Manager software used at
that time. There was no requirement for a description of
justification of any decisions and there was likely incon-
sistency in both the decision-making and the content of
this reporting.
In the 2008 version of the Handbook, there was a
major revision to the RoB tool [15]. This version of the
tool included five bias categories and six mandatory
components. There were options for considerations of
outcome-specific components. The assessment of each
component was done using ‘Yes’, ‘No’ or ‘Unclear’
categories. For each judgement, the review author was
required to include a justification based on text within
the review and where possible, a direct quote.
In 2011, the Handbook was updated and further changes
were made to the RoB tool [16]. To distinguish between
performance bias affecting actual outcomes and detection
bias in their inaccurate estimation, this version of the RoB
tool included a recommendation to separate assessment of
blinding into two components, one for study participants
and intervention providers, and one for outcome assessors,
respectively. Judgements were changed to ‘High risk’,
‘Low risk’ or ‘Unclear risk’, but the requirement to justify
all judgements remained.
In 2008, the Cochrane Handbook suggested that all
Cochrane reviews include a summary of findings (SoF)
table [17]. The risk of bias assessment influences the
reporting of the quality of evidence of specific outcomes
in the SoF table. Previous research has demonstrated that
only 9 % of updated Cochrane reviews have a change in
conclusions compared to the original review [18]. Changes
in the new risk of bias assessments leading to the potential
changes of the content of the SoF tables could influ-
ence the overall conclusions. Further, robustness of
meta-analytic estimates and exploration between study
heterogeneity in estimates of effects is often explored
in sensitivity analyses—repeat primary meta-analyses
limited to subgroups of studies. Changes in study level
risk of bias assessments have the potential to change
estimates of effects in sensitivity analyses and explain
heterogeneity that was previously unexplained.
Given the slow rate of updating, it is common for
newly published review updates to require a full re-
assessment of studies included in earlier versions. For
example, if the original version of a review was pub-
lished in 2004 and updated in 2014, then all originally
included studies would require reassessment using the
2011 RoB tool for methodological consistency. In 2014,
over 400 reviews were updated in CDSR. Over 75 % of
these updates were published as original reviews prior to
January 2011, indicating that at some point, authors
should have reassessed the previously included studies
using a second, more current RoB tool [19].
The 2011 version of RoB improves the transparency
of published reviews and the framework for assessing
risk of bias [20]. Both the additional mandatory categor-
ies and judgements for decisions provide an uncompli-
cated method for authors to judge the impact of the risk
of bias on the review results. Depending on when the
Table 1 A comparison of Cochrane risk of bias approaches since 2006
Risk of bias
version
Biases assessed Specific domains Mandatory component in Review
Manager software
2006 Recommendation was made to assess
selection bias (allocation concealment),
performance bias, attrition bias and
detection bias for every study.
Selection bias (specifically allocation concealment)
was incorporated into Review Manager and scored
as ‘adequate (A), unclear (B), inadequate (C) or that
allocation concealment was not used (D)’. Other
biases were not mandatory and likely not consistently
assessed. No justification of judgement was required.
2008 Development of a tool for assessing
risk of bias. Four biases as above, with
‘other bias’ category for authors to
consider additional biases. No limit on
the number of additional biases
authors can identify.
Sequence generation, allocation concealment,
blinding, incomplete outcome data, selective
outcome reporting and other domains which
authors could add.
Assessment of six domains within five biases
mandatory. Judgement of ‘Yes’ (low risk), ‘No’
(high risk) or ‘Unclear’. Justification of judgement
mandatory for each domain for each study.
2011 2008 tool modified but no new
biases added.
As per 2008 version, except blinding divided
into two domains, one related to blinding
of participants and personnel, and the other
related to outcome assessors.
Judgements changed to ‘High risk’, ‘Low risk’ or
'Unclear risk’. Clarification of which category of bias
domain refers to and additional guidance for other
risk of bias.
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previous version of a review was published, it is clearly a
substantial amount of work for authors of updates to re-
visit all of the included studies in the previous publica-
tion, reassess their risk of bias and adjust the results
accordingly. Though the application of the Cochrane
RoB tool is required as per the Methodological Expecta-
tions of Cochrane Intervention Reviews [21], only 74 %
of Cochrane review groups reported enforcing the ap-
plication of the tool to all randomised controlled trials
when updating a systematic review [22].
Discussion
Possible approaches
There are four different risk of bias scenarios to consider
that reviewers may encounter when updating reviews.
For our purposes, the decision-making has been broken
down into whether studies were included in the original
review, and subsequently, whether any additional eligible
studies were found in the updated search. The different
scenarios are presented with a rationale for, and implica-
tions of, each decision. The scenarios below apply to
reviews for which the research questions and 'popula-
tion-intervention-comparison-outcome', or PICO, frame-
work remain essentially unchanged. When important
changes to the research questions or framework are
required (e.g. new important harms have been identified,
new population and disease indications have emerged,
comparator(s) has changed because another treatment(s)
has now also diffused into current practice, etc.), a new
protocol must be developed to undertake an entirely new
review rather than update an existing one. Decisions at
this time must be made whether to proceed with an up-
date or to publish a new review with the new parameters.
1. Updating reviews where previous version(s) had no
included studies
a. No new eligible studies identified in the updated
search
After complete searching and screening according to
predetermined criteria, there are still some systematic
reviews that have no included studies, commonly
referred to as empty reviews [23, 24]. If no new studies
are found in the search for the updated review, and the
review remains empty, then there is obviously no need
to apply a RoB tool.
b. One or more eligible studies found in the updated
search
If one or more new studies are judged to be eligible
for inclusion in the review from a new recent search, the
clear choice would be to use the current 2011 RoB tool.
The authors would be required to do full data extraction
of the newly included studies and as such, would also be
expected to perform a full assessment of the risk of bias.
2. Updating reviews where previous version(s) had
included studies
a. No new eligible studies identified in the updated
search
One could argue in this case that redoing RoB assess-
ments of previously included studies is not necessary
(Fig. 1). The 2011 Cochrane Handbook does not strongly
recommend the reassessment of included studies when
no new eligible studies are found [25]. However, the only
solid rationalization for not re-evaluating previously in-
cluded studies is a minimization of the work required.
The fact that the review will be labelled, published and
cited as updated implies that the methods used are
current. The best approach is for the authors to reassess
all the original studies using the current RoB tool. As
described above, authors will receive a new citation for
the update, even if there are no new studies included.
The rationale is that updating of reviews is a holistic
undertaking in which all aspects need to be current and
up-to-date; not only searches but also methodological
approaches to critical appraisal and synthesis of evi-
dence. An argument may be made that empiric evidence
does not exist demonstrating meaningful differences
between the current and earlier versions of RoB tool.
Nonetheless, revisions leading to the current tool have
been made based on author and user input. The en-
dorsement of the current tool by the Cochrane Collabor-
ation is reason enough why all studies within a review
should be assessed using the most recent tool.
However, there are important challenges in incorporating
the most current risk of bias tool into an update of a
review. Depending on the age of the review, it is possible
that the authors have performed a risk of bias assessment
on all studies in the previous version of the review using
an older version of the tool. One could argue that older
studies may be subject to a time lag bias as authors of older
studies may have used acceptable methods at the time the
study was conducted, but unfortunately, those studies
would be graded as higher risk of bias based on current
standards. One example of this is trial registration or
protocol publication (or availability) to detect or clarify the
absence of selective outcome reporting. To comply with
the U.S. Food and Drug Administration Modernization
Act (FDAMA) of 1997, clinicaltrials.gov was launched in
2000 as a trial registration platform [26]. Trial registration
became an ICMJE requirement in 2005 [26] and was later
mandated under the U.S. Food and Drug Administration
Amendments Act (FDAAA) of 2007 [27]. Prior to 2005,
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there was no easy process for trial registration, and it was
very rare for protocols to be published for individual trials.
Therefore, older studies are much more likely to receive
an ‘unclear’ RoB assessment of selective outcome report-
ing compared with trials published after 2007. Granted
this may also be true for older included studies included
in the first version of a review, but for updating, we are
recommending authors reassess the reviews which in-
volves additional work and may impact on the results.
Furthermore, authors of older studies would report their
findings according to the journal requirements which may
have been different 10 or more years ago when the
Consolidated Standards of Reporting Trials (CONSORT)
statement was less widely adopted [28].
When writing Cochrane reviews, authors report that a
RoB criterion is ‘unclear’ when the information is not
available. One approach to dealing with the lack of clear
reporting of information is to contact individual study
authors. In principle, this approach seems logical and very
useful. Unfortunately, there are two major limitations.
First of all, it can be very difficult to track down author
teams for individual studies. Researchers change institu-
tions, research interests change and teams split up; as a
result, study processes which may or may not contribute
to RoB may be difficult to recall or report accurately. Sec-
ondly, there is evidence that contacting study authors may
lead to overly positive answers. In a survey of 104 trialists,
using direct questions about blinding with named categor-
ies of trial personnel, 43 % responded that the data ana-
lysts in their double-blind trials were blinded, and 19 %
responded that the manuscript writers were blinded [29].
This is unlikely to be true, given that such procedures
were reported in only 3 and 0 % of the corresponding pub-
lished articles, and that they are very rarely described in
other trial reports. Updating a review is unlikely to change
judgements on a specific criterion which was judged to be
‘unclear’, as it will be even more difficult to obtain infor-
mation from authors because at least two more years will
have passed since the included study was published.
b. One or more studies found in the updated search
The consistency of methods and reporting within a
review is an important issue. Review authors will likely
choose to assess all the studies similarly, either using a
previous RoB tool or the more recent version. However,
as argued above, the best practice approach is for review
authors to apply the 2011 RoB tool to all included stud-
ies, both those included in the previous review publica-
tion and the newly identified studies for inclusion to
maintain review currency and associated face validity,
regardless of the number in each category. The discus-
sion above is relevant for an update with new studies,
and the added concern of consistency within a review
makes it very difficult to rationalise using an old tool for
newly found studies. It is worth noting that if the search
strategy is modified, there may be studies identified
which should be included that were published prior to
the original publication but not captured in the previous
version of the review. The lack of reporting guidelines
and difficulty contacting authors would be an issue for
these newly identified but older studies, but they would
still be included in the review and require a full assess-
ment including risk of bias.
Fig. 1 Options for assessing risk of bias when updating reviews with one or more original studies
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This commentary discusses an important methodological
consideration associated with the updating of systematic
reviews that is currently not being enforced universally as
authors update their systematic reviews. We recommend
that systematic review authors should not only update their
review with new evidence but also ensure that the methods
used are current. This is particularly relevant for the study
risk of bias assessment using the Cochrane RoB tool which
has gone several iterative revisions over the past 10 years.
Although we believe the recommendations are sound,
there are some implications. The original version of a
review would have described in the methods the tech-
niques that would have been used for the RoB assessment.
Theoretically, authors who use the newer RoB tools for an
update would not be following their protocol. It would be
very important for authors to document how the RoB
assessment has changed. Cochrane authors are required to
describe differences between protocol and review, and the
use of a more recent RoB tool in an update should be
clearly documented.
For a new review, in the process of writing the proto-
col, the review authors are expected to consider and
clearly document how they will incorporate the risk of
bias assessments into the results. These same decisions
and documentation should be followed when performing
an update. Authors should refer to the most recent ver-
sion of the Cochrane Handbook for guidance and out-
line in the methods and any changes to the approach of
incorporation of risk of bias assessment into the results.
Authors should also be prepared for the possibility that
results (including judgement about the reviewers’ confi-
dence in the estimates of effects or quality of evidence)
and conclusions may change by incorporating a newer
RoB tool into the methods. Besides the actual shift in
the magnitude and direction of the estimates of effects
with new evidence, using a more current risk of bias tool
could also potentially change the assessment of the
quality of evidence, overall conclusions or both.
It is clear that using the most recent RoB tool for studies
that were assessed in an earlier version of a review,
substantially increases the workload. However, the im-
provements in the methods and the consistency across all
Cochrane reviews are critical. As discussed above, authors
receive full citation credit for an update, and therefore
should meet any expectations of the publishing body.
Implementation of these recommendations will con-
tinue to be a challenge. There are new MECIR standards
being developed for updating Cochrane reviews. Inclu-
sion of our recommendations in the standards and in
the Handbook will likely increase the chance of the rec-
ommendations being followed.
There will continue to be new developments and major
revisions to the RoB tool used in Cochrane reviews. There
is a new RoB tool recently launched for non-randomised
studies [30]. New biases and new assessment tools are be-
ing developed for randomised controlled trials as well, and
there will continue to be a need for authors of updates to
consider the best approach. It is likely that other review
components such as summary of findings tables, searching
and statistical analysis will all continue to evolve and lead
to additional work for authors to consider when updating
reviews. These considerations can also potentially apply to
other methodological aspects of evidence syntheses as cor-
responding guidance evolves—for example, approaches to
meta-analysing sparse data, subgroup analyses and recom-
mendations for assessment of publication bias.
Conclusion
Updating Cochrane reviews, and non-Cochrane reviews,
remains a challenge for many reviewers. Nonetheless,
using the newest version of the RoB tool for all included
studies, even those studies included in the previous
versions of the review, is the recommended approach.
Authors and readers should be well aware of the chal-
lenges newer methods of risk of bias assessments present
when updating Cochrane reviews.
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